puc-header

Human Cytomegalovirus Degrades DMXL1 to Inhibit Autophagy, Lysosomal Acidification and Viral Assembly

51 Pages Posted: 9 Aug 2023 Publication Status: Published

See all articles by Hanqi Li

Hanqi Li

University of Cambridge

Alice Fletcher-Etherington

University of Cambridge - Cambridge Institute for Medical Research

Leah Hunter

University of Cambridge

Swati Keshri

University of Cambridge

Ceri A. Fielding

Cardiff University

Katie Nightingale

University of Cambridge

Benjamin Ravenhill

University of Cambridge

Luis Nobre

University of Cambridge

Robin Antrobus

University of Cambridge - Cambridge Institute for Medical Research

David C. Rubinsztein

University of Cambridge

Richard J. Stanton

Cardiff University

Michael P. Weekes

University of Cambridge - Cambridge Institute for Medical Research; Cambridge University Hospitals NHS Foundation Trust

More...

Abstract

Human cytomegalovirus (HCMV) is an important human pathogen and a master regulator of host intrinsic, innate, and adaptive immunity. HCMV hijacks host intracellular compartments to assemble new virions, and lysosomes are essential for this process. We combined a comprehensive proteomic analysis of host proteins targeted for degradation by HCMV with a database of proteins involved in vacuolar acidification. Dmx-like protein 1 (DMXL1) was the only protein that acidifies vacuoles yet is degraded by HCMV.Systematic comparison of viral deletion mutants revealed that the uncharacterised 7kDa US33A protein is necessary and sufficient for DMXL1 degradation. Functional experiments using cells stably expressing US33A, or infected with adenovirus vectors expressing US33A, or infected with recombinant HCMV deleted for US33A, demonstrated that HCMV degrades DMXL1 to inhibit lysosomal acidification and autophagic cargo degradation. Formation of the viral assembly compartment, which is known to require lysosomes, occurred significantly later in cells infected with US33A-expressing virus, with reduced viral replication. These data thus identify an entirely new viral strategy for cellular remodelling. US33A recruits the E3 ubiquitin ligase Kip1 ubiquitination-promoting complex (KPC) and acts akin to a proteolysis-targeting chimera (PROTAC) to degrade DMXL1. The potential thus exists to employ US33A in novel therapies for viral infection or rheumatic conditions, in which inhibition of lysosome acidification can attenuate disease.

Note:
Funding Information: This work was supported by a Medical Research Council Project Grant (MR/X000516/1) to MPW, a MRC grant (MR/S00971X/1) to RJS, the UK Dementia Research Institute (funded by the MRC, Alzheimer’s Research UK and the Alzheimer’s Society), The Cambridge Commonwealth, European & International Trust (SK), the Nehru Trust for Cambridge University and the Trinity-Henry Barlow Scholarship (SK) and the NIHR Cambridge Biomedical Research Centre (NIHR203312).

Declaration of Interests: DCR is a consultant for Aladdin Healthcare Technologies Ltd., Mindrank AI, Nido Biosciences, Drishti Discoveries, Retro Biosciences and PAQ Therapeutics. None of the other authors have any interests to declare.

Keywords: proteomics, systems virology, human cytomegalovirus, lysosome, pH, viral replication, viral assembly, autophagy

undefined

Suggested Citation

Li, Hanqi and Fletcher-Etherington, Alice and Hunter, Leah and Keshri, Swati and Fielding, Ceri A. and Nightingale, Katie and Ravenhill, Benjamin and Nobre, Luis and Antrobus, Robin and Rubinsztein, David C. and Stanton, Richard J. and Weekes, Michael P., Human Cytomegalovirus Degrades DMXL1 to Inhibit Autophagy, Lysosomal Acidification and Viral Assembly. Available at SSRN: https://ssrn.com/abstract=4531950 or http://dx.doi.org/10.2139/ssrn.4531950
This version of the paper has not been formally peer reviewed.

Hanqi Li

University of Cambridge ( email )

Trinity Ln
Cambridge, CB2 1TN
United Kingdom

Alice Fletcher-Etherington

University of Cambridge - Cambridge Institute for Medical Research ( email )

Trinity Ln
Cambridge, CB2 1TN
United Kingdom

Leah Hunter

University of Cambridge ( email )

Trinity Ln
Cambridge, CB2 1TN
United Kingdom

Swati Keshri

University of Cambridge ( email )

Trinity Ln
Cambridge, CB2 1TN
United Kingdom

Ceri A. Fielding

Cardiff University ( email )

Katie Nightingale

University of Cambridge ( email )

Trinity Ln
Cambridge, CB2 1TN
United Kingdom

Benjamin Ravenhill

University of Cambridge ( email )

Trinity Ln
Cambridge, CB2 1TN
United Kingdom

Luis Nobre

University of Cambridge ( email )

Trinity Ln
Cambridge, CB2 1TN
United Kingdom

Robin Antrobus

University of Cambridge - Cambridge Institute for Medical Research ( email )

Trinity Ln
Cambridge, CB2 1TN
United Kingdom

David C. Rubinsztein

University of Cambridge ( email )

Trinity Ln
Cambridge, CB2 1TN
United Kingdom

Richard J. Stanton

Cardiff University ( email )

Michael P. Weekes (Contact Author)

University of Cambridge - Cambridge Institute for Medical Research ( email )

Cambridge University Hospitals NHS Foundation Trust ( email )

0 References

    0 Citations

      Click here to go to Cell.com

      Paper statistics

      Downloads
      20
      Abstract Views
      430
      PlumX Metrics